ARCHIVES

Tasigna Shows Benefit Over Gleevec In Phase III Study for Ph+ CML In Chronic Phase

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

Richard Bloch’s Dream Of Empowering Patients Had Rough Beginning

October 11, 1996

Advisors seek support for NCI’s “special authorities” granted in 1971.

July 15, 2005

Interview with Christine Berg: ST Findings Relevant Only To High-Risk;

November 26, 2010

Rosenberg Team May Have Cloned Melanoma Gene

May 31, 1991

Cancer Policy; Board Suggests More Detailed Items In Tobacco Agreement

August 22, 1997

House Members Express Support for Cancer Program

September 12, 1980